Pediatrix Medical Group, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $42.74M, a 20351.67% increase year-over-year.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $21.45M, a 1267.18% increase year-over-year.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $64.04M, a 9859.25% increase year-over-year.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $20.87M, a 12780.86% increase year-over-year.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for fiscal 2025 was $86.68M, a 4990.02% increase from fiscal 2024.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for fiscal 2024 was $1.70M, a 85.31% increase from fiscal 2023.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for fiscal 2023 was $919.00K, a 98.96% decline from fiscal 2022.
- Pediatrix Medical Group, Inc. payments for repurchase of common stock for fiscal 2022 was $88.51M, a 1775.63% increase from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $42.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $149.10M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $21.45M 10-Q · filed 2026-05-05 | $106.56M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $64.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $86.68M 10-K · filed 2026-02-19 |
| 2025-09-30 | $20.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $23.29M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.57M 10-Q · filed 2026-05-05 | $2.38M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $643.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.70M 10-K · filed 2026-02-19 |
| 2024-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $1.06M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.03M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $887.00K 10-Q · filed 2025-05-06 | $1.03M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $919.00K 10-K · filed 2026-02-19 |
| 2023-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $2.39M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $23.73M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $775.00K 10-Q · filed 2024-05-07 | $88.12M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $88.51M 10-K · filed 2025-02-20 |
| 2022-09-30 | $21.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $87.04M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $64.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $68.04M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $1.17M 10-Q · filed 2023-05-02 | $3.89M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.72M 10-K · filed 2024-02-20 |
| 2021-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.72M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $251.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $7.70M derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $1.99M 10-Q · filed 2022-04-28 | $7.95M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $8.49M 10-K · filed 2023-02-17 |
| 2020-09-30 | $5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $8.85M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $501.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.81M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $2.54M 10-Q · filed 2021-05-07 | $68.84M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $145.28M 10-K · filed 2022-02-17 |
| 2019-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $144.93M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-06-30 | $65.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $394.51M derived: sum of 4 quarters · filed 2021-02-18 |
| 2019-03-31 | $78.98M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $302.16M 10-K · filed 2021-02-18 |
| 2018-09-30 | $250.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $70.19M 10-K · filed 2020-02-20 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $70.19M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $70.19M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $68.11M 10-Q · filed 2018-05-04 | $71.30M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $61.83M 10-K · filed 2019-02-14 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $61.83M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $63.28M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-03-31 | $58.65M 10-Q · filed 2017-05-04 | $60.10M derived: sum of 4 quarters · filed 2018-02-14 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $235.05M 10-K · filed 2018-02-14 |
| 2015-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $595.72M derived: sum of 4 quarters · filed 2017-02-10 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $595.33M derived: sum of 4 quarters · filed 2017-02-10 |
| 2015-03-31 | $233.60M 10-Q · filed 2016-04-28 | $605.04M derived: sum of 4 quarters · filed 2017-02-10 |
| 2014-12-31 | $360.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-10 | $488.43M 10-K · filed 2017-02-10 |
| 2014-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $127.76M derived: sum of 4 quarters · filed 2016-02-11 |
| 2014-06-30 | $9.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | |
| 2014-03-31 | $116.99M 10-Q · filed 2015-04-30 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $51.86M 10-K · filed 2016-02-11 |
| 2008-12-31 | $200.00M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |